Child Healthcare at MATER - Pediatric Study

Description

The objective of this project is to implement and evaluate a group model of well child care for mothers in treatment for opioid use disorder and their children that addresses the specific health needs and concerns of opioid-exposed infants, is trauma informed, and is embedded within a maternal opioid use disorder treatment program. 108 mother-infant dyads will be randomized 1:1 to group well child care or individual well child care, and followed over an 18 month period. Qualitative and quantitative data will be collected at multiple time points. The efficacy of group well child care to improve health and healthcare-related outcomes will be evaluated.

Conditions

Opioid Use Disorder

Study Overview

Study Details

Study overview

The objective of this project is to implement and evaluate a group model of well child care for mothers in treatment for opioid use disorder and their children that addresses the specific health needs and concerns of opioid-exposed infants, is trauma informed, and is embedded within a maternal opioid use disorder treatment program. 108 mother-infant dyads will be randomized 1:1 to group well child care or individual well child care, and followed over an 18 month period. Qualitative and quantitative data will be collected at multiple time points. The efficacy of group well child care to improve health and healthcare-related outcomes will be evaluated.

Well Child Care Intervention for Infants of Mothers in Treatment for Opioid Use Disorder

Child Healthcare at MATER - Pediatric Study

Condition
Opioid Use Disorder
Intervention / Treatment

-

Contacts and Locations

Philadelphia

Thomas Jefferson University, Philadelphia, Pennsylvania, United States, 19106

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * at least 28 weeks pregnant or less than 2 weeks postpartum
  • * receiving treatment for opioid use disorder
  • * ability to read and speak English
  • * plans to parent infant after delivery
  • * intent to seek pediatric care within Nemours/Thomas Jefferson University system
  • * intent to remain in the Philadelphia area for the next 2 years
  • * inability to speak English
  • * plans to move outside of the Philadelphia area in the next 2 years
  • * plans to not parent infant after delivery
  • * plans to seek pediatric care outside of the Nemours/Thomas Jefferson University System

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

FEMALE

Accepts Healthy Volunteers

No

Collaborators and Investigators

Thomas Jefferson University,

Vanessa Short, PhD, PRINCIPAL_INVESTIGATOR, Thomas Jefferson University

Neera Goyal, MD, PRINCIPAL_INVESTIGATOR, Nemours Al DuPont Pediatrics

Study Record Dates

2025-10